PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron

PI3K-α/mTOR/BRD4 억제제 단독 또는 다른 항바이러스제와 함께 SARS-CoV-2 및 Delta 및 Omicron을 포함한 우려되는 변종 복제 차단

Published on 2022-04-012022-09-11
Journal: Clinical and Translational Medicine

[저자] Arpan Acharya, Anup S Pathania, Kabita Pandey, Michellie Thurman, Kendra R Vann, Tatiana G Kutateladze, Kishore B Challagundala, Donald L Durden, Siddappa N Byrareddy

[Category] COVID19(2023년), SARS, 변종, 치료제,

PMC URL [DOI] 10.1002/ctm2.806

[Article Type] Article

[Source] PMC

All Keywords
【제목키워드】 variants of concern, Delta, omicron, Anti-viral, inhibitor, Combination, replication of SARS-CoV-2, block,